Amphastar Pharmaceuticals

Amphastar Pharmaceuticals

World Rank (Aug-2026)
9798
Market Cap (Aug-2026)
0.889 Billion USD
Market Cap (Mar-08-2026)
0.877 Billion USD
World Rank (Jan-05-2024)
4,332
Market Cap (Jan-05-2024)
3.040 Billion USD
World Rank (Jul-30-2023)
4,422
Market Cap (Jul-30-2023)
2.937 Billion USD
World Rank (Jan-07-2022)
8,516
Market Cap (Jan-07-2022)
1.199 Billion USD
World Rank (Jan-01-2021)
8,133
Market Cap (Jan-01-2021)
0.955 Billion USD
Headquarters Country
USA
Top Healthcare Companies in USA
Top Pharmaceutical Companies in USA
Nasdaq / NYSE Code
AMPH
Employee Count
1,761
Employee Count as of Date
As on 2021
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
720 Million USD
Annual Operating Income in USD
140 Million USD
Annual Net Income in USD
98 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
1,629 Million USD
Total Liabilities in USD
840 Million USD
Total Equity in USD
789 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Pharmaceutical
HealthCare Products
Company Website
Amphastar Pharmaceuticals
Yahoo
Yahoo @ Nasdaq
Company Profile
Amphastar Pharmaceuticals is a Specialty Pharmaceutical company that is engaged in the development, manufacture and marketing of generic and proprietary injectable, intranasal and inhalation products. It produce over 20 commercial products while continue to develop a portfolio of generic and branded products that target large markets with high technical barriers to entry. The headquarters is in USA.
IPO Year
2014
Stock Exchange
Nasdaq
Frankfurt
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share